Covey, Thomas H.; Sherman, Laurence
March 1975
Angiology;Mar1975, Vol. 26 Issue 3, p289
Academic Journal
The 125I fibrinogen uptake test is a highly sensitive indicator of early thrombophlebitis involving the deep veins of the calf and lower thigh. It is objective, accurate and reproducible in the hands of a trained technician. It has minimal risk, if proper precautions are taken (particularly in the selection of donors) and can be used at the bedside for daily monitoring with no discomfort to the patient. These characteristics make the 125I fibrinogen uptake test an extremely valuable tool for prospective study of hospitalized patients to determine the natural history of deep vein thrombosis, its prevention and treatment.


Related Articles

  • DIAGNOSIS OF ESTABLISHED DEEP-VEIN THROMBOSIS IN THE LEG USING 131 I FIBRINOGEN. Partsch, H.; Lofferer, O.; Mostbeck, A. // Angiology;Dec1974, Vol. 25 Issue 11, p719 

    The 131 I fibrinogen test is not only a useful and simple test for the early detection of occult forming thrombosis, but also a satisfactorily accurate method for confirming the clinical diagnosis of established deep vein thrombosis. This was shown by three groups of experiments in a total of...

  • Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Kozek-Langenecker, Sibylle; Sørensen, Benny; Hess, John R.; Spahn, Donat R. // Critical Care;2011, Vol. 15 Issue 5, p1 

    Introduction: Haemostatic therapy in surgical and/or massive trauma patients typically involves transfusion of fresh frozen plasma (FFP). Purified human fibrinogen concentrate may offer an alternative to FFP in some instances. In this systematic review, we investigated the current evidence for...

  • FIBRINOGEN. Schnell, Zoanne Burgess; Van Leeuwen, Anne M.; Kranpitz, Todd R. // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2003, p511 

    Presents a comprehensive guide to laboratory and diagnostic tests for fibrinogen. Use of the test in terms of assessment, evaluation and assisting in the diagnosis of a clinical condition; Interfering factors that may influence the results; Nursing implications and procedure.

  • Fibrinogen and Fibrinogen Degradation Product Levels in Thromboangiitis Obliterans. Gulati, Surinder Mohan; Chandra, Vidhan; Narayan, Shashi // Vascular Surgery;Mar1993, Vol. 27 Issue 2, p105 

    Fibrinogen and fibrinogen degradation product levels were estimated in 20 patients with thromboangiitis obliterans and compared with those in healthy smokers and patients with other peripheral vascular diseases. The presence of increased fibrinogen levels in patients with thromboangiitis...

  • FIBRINOGEN ESTIMATION BY PAPER ELECTROPHORESIS. Reece, M. W.; Jepson, R. P. // Angiology;Aug1957, Vol. 8 Issue 4, p323 

    1. A technique is described for the separation of fibrinogen by paper electrophoresis and the effects of various anticoagulants are compared: the best results were obtained with a veronal buffer and with heparin as anticoagulant. 2. Numerous difficulties, including that of avoiding denaturation...

  • Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report. Bosevski, Marijan; Bosevska, Golubinka; Stojanovska, Lily // Cardiovascular Diabetology;2013, Vol. 12 Issue 1, p1 

    Background: Limited studies have suggested that inflammatory biomarkers play a role in the initiation and progression of atherosclerosis in diabetic patients. This study assesses the effect of inflammatory biomarkers: fibrinogen and C-reactive protein (C-RP) on the progression of peripheral...

  • FIBRINOGEN  // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2006, p652 

    Fibrinogen (factor I) is synthesized in the liver. In the common final pathway of the coagulation sequence, thrombin converts fibrinogen to fibrin, which then clots blood as it combines with platelets. In normal, healthy individuals, the serum should contain no residual fibrinogen after clotting...

  • Congenital afibrinogenaemia caused by uniparental isodisomy of chromosome 4 containing a novel 15-kb deletion involving fibrinogen Aa-chain gene. Spena, Silvia; Duga, Stefano; Asselta, Rosanna; Peyvandi, Flora; Mahasandana, Chularatana; Malcovati, Massimo; Tenchini, Maria Luisa // European Journal of Human Genetics;Nov2004, Vol. 12 Issue 11, p891 

    Among rare inherited deficiencies of coagulation factors, congenital afibrinogenaemia is characterised by the lack of fibrinogen in plasma. In the last few years, several genetic defects underlying afibrinogenaemia (mostly point mutations) have been described in the fibrinogen gene cluster. In...

  • Influence of Fibrinogen Deficiency on Clot Formation in Flow by Hybrid Model. Tosenberger, A.; Bessonov, N.; Volpert, V. // Mathematical Modelling of Natural Phenomena;Jan2015, Vol. 10 Issue 1, p36 

    In this work we develop the 2D model suggested in [32] in order to study the impact of fibrinogen concentration and the fibrin polymer production rate on clot growth in flow. The model is based on the method of Dissipative Particle Dynamics describing blood plasma flow and platelet suspension...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics